In this study, we identified that SOCs are potent regulators of dystrophin deficiency-mediated Ca2+ overload in myotubes differentiated from DMD patient-derived iPSCs using small-scale chemical screening. The gene discussed is CISH; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.